Logo image of CRMT

AMERICA'S CAR-MART INC (CRMT) Stock Fundamental Analysis

USA - NASDAQ:CRMT - US03062T1051 - Common Stock

30.27 USD
-0.42 (-1.37%)
Last: 9/26/2025, 8:00:00 PM
30.27 USD
0 (0%)
After Hours: 9/26/2025, 8:00:00 PM
Fundamental Rating

3

CRMT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. There are concerns on the financial health of CRMT while its profitability can be described as average. CRMT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CRMT was profitable.
CRMT had a negative operating cash flow in the past year.
CRMT had positive earnings in 4 of the past 5 years.
In the past 5 years CRMT always reported negative operating cash flow.
CRMT Yearly Net Income VS EBIT VS OCF VS FCFCRMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

With a Return On Assets value of 0.82%, CRMT perfoms like the industry average, outperforming 54.10% of the companies in the same industry.
With a Return On Equity value of 2.32%, CRMT perfoms like the industry average, outperforming 56.56% of the companies in the same industry.
CRMT's Return On Invested Capital of 4.57% is in line compared to the rest of the industry. CRMT outperforms 54.92% of its industry peers.
CRMT had an Average Return On Invested Capital over the past 3 years of 3.44%. This is significantly below the industry average of 11.93%.
The 3 year average ROIC (3.44%) for CRMT is below the current ROIC(4.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.82%
ROE 2.32%
ROIC 4.57%
ROA(3y)0.14%
ROA(5y)4.28%
ROE(3y)0.19%
ROE(5y)9.25%
ROIC(3y)3.44%
ROIC(5y)7.19%
CRMT Yearly ROA, ROE, ROICCRMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

CRMT's Profit Margin of 0.95% is in line compared to the rest of the industry. CRMT outperforms 55.74% of its industry peers.
CRMT's Profit Margin has declined in the last couple of years.
CRMT has a Operating Margin of 6.23%. This is in the better half of the industry: CRMT outperforms 72.95% of its industry peers.
In the last couple of years the Operating Margin of CRMT has declined.
Looking at the Gross Margin, with a value of 48.39%, CRMT is in the better half of the industry, outperforming 76.23% of the companies in the same industry.
In the last couple of years the Gross Margin of CRMT has remained more or less at the same level.
Industry RankSector Rank
OM 6.23%
PM (TTM) 0.95%
GM 48.39%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
CRMT Yearly Profit, Operating, Gross MarginsCRMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRMT is destroying value.
CRMT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRMT has more shares outstanding
CRMT has a better debt/assets ratio than last year.
CRMT Yearly Shares OutstandingCRMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
CRMT Yearly Total Debt VS Total AssetsCRMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that CRMT is in the distress zone and has some risk of bankruptcy.
CRMT has a Altman-Z score (1.79) which is in line with its industry peers.
CRMT has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.38, CRMT is not doing good in the industry: 63.93% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Altman-Z 1.79
ROIC/WACC0.49
WACC9.36%
CRMT Yearly LT Debt VS Equity VS FCFCRMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.29 indicates that CRMT should not have too much problems paying its short term obligations.
CRMT has a Current ratio of 1.29. This is comparable to the rest of the industry: CRMT outperforms 48.36% of its industry peers.
CRMT has a Quick Ratio of 1.29. This is a bad value and indicates that CRMT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.44, CRMT is in line with its industry, outperforming 42.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.44
CRMT Yearly Current Assets VS Current LiabilitesCRMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 112.22% over the past year.
Measured over the past years, CRMT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -30.02% on average per year.
The Revenue has been growing slightly by 0.79% in the past year.
CRMT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.31% yearly.
EPS 1Y (TTM)112.22%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%-360%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%-1.85%

3.2 Future

The Earnings Per Share is expected to grow by 59.25% on average over the next years. This is a very strong growth
CRMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.33% yearly.
EPS Next Y-11.98%
EPS Next 2Y81.79%
EPS Next 3Y59.25%
EPS Next 5YN/A
Revenue Next Year8.96%
Revenue Next 2Y7.01%
Revenue Next 3Y4.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRMT Yearly Revenue VS EstimatesCRMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CRMT Yearly EPS VS EstimatesCRMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 43.24, CRMT can be considered very expensive at the moment.
CRMT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CRMT to the average of the S&P500 Index (27.54), we can say CRMT is valued expensively.
A Price/Forward Earnings ratio of 7.39 indicates a rather cheap valuation of CRMT.
CRMT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRMT is cheaper than 94.26% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.05. CRMT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 43.24
Fwd PE 7.39
CRMT Price Earnings VS Forward Price EarningsCRMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CRMT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.8
CRMT Per share dataCRMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as CRMT's earnings are expected to grow with 59.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.79%
EPS Next 3Y59.25%

0

5. Dividend

5.1 Amount

CRMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICA'S CAR-MART INC

NASDAQ:CRMT (9/26/2025, 8:00:00 PM)

After market: 30.27 0 (0%)

30.27

-0.42 (-1.37%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-04 2025-09-04/bmo
Earnings (Next)12-03 2025-12-03/bmo
Inst Owners87.77%
Inst Owner Change-3.65%
Ins Owners15.1%
Ins Owner Change-14.54%
Market Cap250.64M
Analysts80
Price Target51 (68.48%)
Short Float %11.68%
Short Ratio6.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-1.73%
DP0.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-73.22%
Min EPS beat(2)-175.75%
Max EPS beat(2)29.31%
EPS beat(4)2
Avg EPS beat(4)-14.19%
Min EPS beat(4)-175.75%
Max EPS beat(4)229.77%
EPS beat(8)2
Avg EPS beat(8)-126.43%
EPS beat(12)2
Avg EPS beat(12)-104.05%
EPS beat(16)4
Avg EPS beat(16)-78.81%
Revenue beat(2)1
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-6.84%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-6.84%
Max Revenue beat(4)8.15%
Revenue beat(8)4
Avg Revenue beat(8)-1.78%
Revenue beat(12)7
Avg Revenue beat(12)-0.02%
Revenue beat(16)11
Avg Revenue beat(16)1.45%
PT rev (1m)-12.79%
PT rev (3m)-4.76%
EPS NQ rev (1m)-63.74%
EPS NQ rev (3m)-51.98%
EPS NY rev (1m)-70.33%
EPS NY rev (3m)-68.59%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)1.46%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)3.81%
Valuation
Industry RankSector Rank
PE 43.24
Fwd PE 7.39
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.46
EV/EBITDA 10.8
EPS(TTM)0.7
EY2.31%
EPS(NY)4.1
Fwd EY13.54%
FCF(TTM)-5.2
FCFYN/A
OCF(TTM)-4.8
OCFYN/A
SpS167.21
BVpS68.26
TBVpS65.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.82%
ROE 2.32%
ROCE 5.84%
ROIC 4.57%
ROICexc 4.6%
ROICexgc 4.68%
OM 6.23%
PM (TTM) 0.95%
GM 48.39%
FCFM N/A
ROA(3y)0.14%
ROA(5y)4.28%
ROE(3y)0.19%
ROE(5y)9.25%
ROIC(3y)3.44%
ROIC(5y)7.19%
ROICexc(3y)3.46%
ROICexc(5y)7.23%
ROICexgc(3y)3.51%
ROICexgc(5y)7.31%
ROCE(3y)4.38%
ROCE(5y)9.16%
ROICexcg growth 3Y-20.68%
ROICexcg growth 5Y-14.67%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-14.71%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Debt/EBITDA 8.31
Cap/Depr 42.56%
Cap/Sales 0.24%
Interest Coverage 1.22
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.44
Altman-Z 1.79
F-Score4
WACC9.36%
ROIC/WACC0.49
Cap/Depr(3y)178.38%
Cap/Depr(5y)233.56%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.22%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%-360%
EPS Next Y-11.98%
EPS Next 2Y81.79%
EPS Next 3Y59.25%
EPS Next 5YN/A
Revenue 1Y (TTM)0.79%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%-1.85%
Revenue Next Year8.96%
Revenue Next 2Y7.01%
Revenue Next 3Y4.33%
Revenue Next 5YN/A
EBIT growth 1Y272.22%
EBIT growth 3Y-11.16%
EBIT growth 5Y5.33%
EBIT Next Year423.72%
EBIT Next 3Y97.66%
EBIT Next 5YN/A
FCF growth 1Y68.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.11%
OCF growth 3YN/A
OCF growth 5YN/A